Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
A: It is the first triple agonist (GLP-1 + GIP + Glucagon) studied in Phase 3 trials
The development of oral GLP-1 drugs is a major focus, as tablets are generally easier and cheaper to manufacture at scale than injectables
Carrero JJ, Barany P, Yilmaz MI, Qureshi AR, Sonmez A, Heimburger O,
The Promise of Injectable GLP-1 Receptor Agonists: Reshaping Strategies in Obesity Treatment The escalating prevalence of obesity presents a pressing public health challenge
Weiss, J
US$ 20.57
US$ 24.89
US$ 26.98
US$ 29.35
US$ 29.61
US$ 28.00
US$ 21.28
US$ 24.05
